Cargando…

Heterogeneity of neuroblastoma

Detalles Bibliográficos
Autor principal:	Ngan, Elly Sau-Wai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671945/ https://www.ncbi.nlm.nih.gov/pubmed/26682270

Ejemplares similares

Multidimensional intratumour heterogeneity in neuroblastoma
por: von Stedingk, Kristoffer, et al.
Publicado: (2019)

New insights empowered by single-cell sequencing: From neural crest to enteric nervous system
por: Li, Zhixin, et al.
Publicado: (2022)

Human Pluripotent Stem Cell-Based Models for Hirschsprung Disease: From 2-D Cell to 3-D Organoid Model
por: Lui, Kathy Nga-Chu, et al.
Publicado: (2022)

Neuroblastoma by chance
por: Tonini, Gian Paolo
Publicado: (2019)

Origin and mechanism of neuroblastoma
por: Tsubota, Shoma, et al.
Publicado: (2017)

Neuroblastoma cancer in children
por: Nagaich, Upendra
Publicado: (2019)

Molecular Determinants of Neuroblastoma
por: Morandi, Fabio
Publicado: (2022)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

Genetic heterogeneity and clonal evolution in neuroblastoma
por: Mora, J, et al.
Publicado: (2001)

Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies
por: Lundberg, Kristina Ihrmark, et al.
Publicado: (2022)

Fighting Neuroblastomas with NBAT1
por: Pandey, Gaurav Kumar, et al.
Publicado: (2015)

The role of ICAM-2 in neuroblastoma
por: Yoon, Karina J., et al.
Publicado: (2015)

CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016)

Surgical Advances in Paediatric Neuroblastoma
por: Martucciello, Giuseppe
Publicado: (2022)

BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids
por: Luo, Juan, et al.
Publicado: (2022)

Mutational topography reflects clinical neuroblastoma heterogeneity
por: Rodriguez-Fos, Elias, et al.
Publicado: (2023)

Spy1/SpeedyA accelerates neuroblastoma
por: Bisteau, Xavier, et al.
Publicado: (2014)

Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity
por: Aktaş, Tekincan Çağrı, et al.
Publicado: (2023)

Spy'ing on differentiation in neuroblastoma
por: Podkowa, Monika, et al.
Publicado: (2014)

Organoid models of breathing disorders reveal patterning defect of hindbrain neurons caused by PHOX2B-PARMs
por: Lui, Kathy Nga-Chu, et al.
Publicado: (2023)

High-SETD8 inactivates p53 in neuroblastoma
por: Veschi, Veronica, et al.
Publicado: (2017)

GDE2/GDPD5 in neuroblastoma
por: Matas-Rico, Elisa, et al.
Publicado: (2016)

Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
por: Matthay, K K, et al.
Publicado: (2000)

Neuroblastoma Mass Screening—What Can We Learn From It?
por: Katanoda, Kota
Publicado: (2016)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

Intrinsic transcriptional heterogeneity in neuroblastoma guides mechanistic and therapeutic insights
por: Shendy, Noha A.M., et al.
Publicado: (2022)

The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016)

Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma
por: Ghaghada, Ketan B., et al.
Publicado: (2016)

Single-cell transcriptome sequencing reveals tumor heterogeneity in family neuroblastoma
por: Zhang, Yunlong, et al.
Publicado: (2023)

Screening for Neuroblastoma Using Urinary Catecholamines: The End of the Story
por: Woods, William G
Publicado: (2021)

Reversible Adaptive Plasticity: A Mechanism for Neuroblastoma Cell Heterogeneity and Chemo-Resistance
por: Chakrabarti, Lina, et al.
Publicado: (2012)

CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
por: Carlisle, Alex J, et al.
Publicado: (2009)

Expression Patterns of Immune Genes Reveal Heterogeneous Subtypes of High-Risk Neuroblastoma
por: Liu, Zhenqiu, et al.
Publicado: (2020)

A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma
por: Cai, Ling, et al.
Publicado: (2023)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Management of neuroblastoma: a study of first- and second-line chemotherapy responses, a single institution experience
por: Habib, Emmad E., et al.
Publicado: (2012)

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion
por: Villamón, Eva, et al.
Publicado: (2013)

Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
por: Hsu, Chia-Lang, et al.
Publicado: (2016)

Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function
por: Ollé Hurtado, Marina, et al.
Publicado: (2019)

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
por: López-Carrasco, Amparo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hv9hu5gqvsb6agjkli936und8g